Show items per page
Elements: 106
Page 3 on 3
 TitleAuthors / EditorsDate
add to browser selection
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study Ledergerber, Bruno; Egger, M.; Erard, V.; Weber, R.; ... Telenti, A. 1999
add to browser selection
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study Ledergerber, Bruno; Egger, M.; Opravil, M.; Telenti, A.; ... Weber, R. 1999
add to browser selection
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study Furrer, Hansjakob; Egger, M.; Opravil, M.; Bernasconi, Enos; ... Malinverni, R. 1999
add to browser selection
Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort Study Lorenzi, P.; Opravil, M.; Hirschel, Bernard; Chave, J. P.; ... Yerly Ferrillo, Sabine 1999
add to browser selection
A critical assessment of the prognostic value of HIV-1 RNA levels and CD4+ cell counts in HIV-infected patients. The Swiss HIV Cohort Study Yerly Ferrillo, Sabine; Perneger, T. V.; Hirschel, Bernard; Dubuis, O.; ... Perrin, Luc 1998
add to browser selection
Low doses of zidovudine plus didanosine are less effective than higher doses of didanosine monotherapy: a randomized trial in patients pretreated with zidovudine Sudre, Philippe; Chave, J. P.; Ruef, Christian; Iten, A.; ... Hirschel, Bernard 1997
| 1 | 2 | 3 | next >>